Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor
- PMID: 1850944
- DOI: 10.1159/000204864
Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor
Abstract
To clarify the correlation of cytokine level with the severity and prognosis of children with the hemophagocytic syndrome, we analyzed serum interleukin-1 (IL-1) and tumor necrosis factor (TNF) levels in 26 children with either the virus-associated hemophagocytic syndrome (VAHS, n = 12) or malignant histiocytosis (MH, n = 14). When compared to healthy controls, 13 children had an elevated IL-1 (greater than or equal to 20 pg/ml) and 21 children had an elevated TNF (greater than or equal to 10 pg/ml) level at diagnosis. There was however, no significant difference in the frequency of these high levels between the patients with VAHS and MH. Neither IL-1 nor TNF levels correlated with other clinical or laboratory findings in either VAHS or MH. Two of the 12 patients with VAHS died of an intracranial hemorrhage and 7 of the 14 patients with MH died despite chemotherapy. The MH patients who had a high TNF level (greater than or equal to 50 pg/ml) had a poorer prognosis than those with a low TNF level (less than 50 pg/ml; p less than 0.01). In MH patients, other parameters, such as coagulopathy and lactic dehydrogenase, ferritin and IL-1 levels, did not correlate with prognosis. In 3 patients (2 with VAHS and 1 with MH) analyzed periodically, the change in TNF level was closely associated with the clinical progression or regression of the diseases. Serum cytokine levels may thus be monitored not only for predicting the severity and prognosis of VAHS or MH but also for determining the indications for or timing of chemotherapy. Moreover, TNF may play an important role in the progression of VAHS and MH.
Similar articles
-
Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis. A survey of pediatric cases.Acta Paediatr Scand. 1989 Mar;78(2):268-70. doi: 10.1111/j.1651-2227.1989.tb11068.x. Acta Paediatr Scand. 1989. PMID: 2929350
-
High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome.Cancer. 1988 May 15;61(10):2071-6. doi: 10.1002/1097-0142(19880515)61:10<2071::aid-cncr2820611023>3.0.co;2-6. Cancer. 1988. PMID: 3359404
-
Host defensive, immunological, and microbiological observations of an early-onset periodontitis patient with virus-associated hemophagocytic syndrome.J Periodontol. 1997 Dec;68(12):1223-30. doi: 10.1902/jop.1997.68.12.1223. J Periodontol. 1997. PMID: 9444599
-
The use of cyclosporin-A in the treatment of virus-associated hemophagocytic syndrome in adults.Leuk Lymphoma. 1997 Dec;28(1-2):73-82. doi: 10.3109/10428199709058333. Leuk Lymphoma. 1997. PMID: 9498706 Review.
-
[Virus-associated hemophagocytic syndrome. Diagnosis and treatment].Ugeskr Laeger. 1998 Oct 19;160(43):6198-200. Ugeskr Laeger. 1998. PMID: 9803867 Review. Danish.
Cited by
-
Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state.Eur J Pediatr. 1995 Jul;154(7):539-41. doi: 10.1007/BF02074830. Eur J Pediatr. 1995. PMID: 7556319
-
[IL-1 antagonists].Z Rheumatol. 2010 Sep;69(7):581-93. doi: 10.1007/s00393-009-0530-7. Z Rheumatol. 2010. PMID: 20703489 German.
-
Inflammatory stress and sarcomagenesis: a vicious interplay.Cell Stress Chaperones. 2014 Jan;19(1):1-13. doi: 10.1007/s12192-013-0449-4. Epub 2013 Aug 27. Cell Stress Chaperones. 2014. PMID: 24046208 Free PMC article. Review.
-
Cytokine-induced hypoalbuminemia in a patient with hemophagocytic syndrome: direct in vitro evidence for the role of tumor necrosis factor-alpha.Dig Dis Sci. 1998 Jan;43(1):67-73. doi: 10.1023/a:1018871920247. Dig Dis Sci. 1998. PMID: 9508537 No abstract available.
-
Age-dependent levels of select immunological mediators in sera of healthy children.Clin Diagn Lab Immunol. 1998 Jan;5(1):28-32. doi: 10.1128/CDLI.5.1.28-32.1998. Clin Diagn Lab Immunol. 1998. PMID: 9455875 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical